Showing results (301-310 of 513) with videos related to

Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2017
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 StudyChiun Hsu, Se-Hoon Lee, Samuel Ejadi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2012
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocationJune Koo Lee, Tae Min Kim, Youngil Koh, et al.
International Journal of Hematology|March 10, 2004
Tuberculosis in hematopoietic stem cell transplant recipients in KoreaJeeyun Lee, Mark H Lee, Won Seog Kim, et al.
Journal of Neuro-Oncology|March 15, 2003
Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiformeIn Sil Choi, Se Hoon Lee, Tae-You Kim, et al.
Cancer Research and Treatment|May 27, 2017
Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II StudyKi Sun Jung, Su Jin Lee, Se Hoon Park, et al.
BMC Ophthalmology|January 11, 2020
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitorsEunhae Shin, Dong Hui Lim, Jisang Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2023
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced NSCLCTae Hee Hong, Yeong Hak Bang, Cheol Yong Joe, et al.
Translational Lung Cancer Research|March 18, 2024
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analysesSehhoon Park, Jun-Kyu Kang, Naeun Lee, et al.
Cellular Signalling|September 29, 2004
Activation of Raf1 and the ERK pathway in response to l-ascorbic acid in acute myeloid leukemia cellsSeyeon Park, Chan H Park, Eun-Ryeong Hahm, et al.
Cancer Research and Treatment|August 19, 2009
Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancerHye Jin Kim, Jin-Soo Kim, Myung-Deok Seo, et al.
Pageof 52